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Prieto-Lloret J, Snetkov VA, Shaifta Y, Docio I, Connolly MJ,
MacKay CE, Knock GA, Ward JP, Aaronson PI. Role of reactive
oxygen species and sulfide-quinone oxoreductase in hydrogen sulfide-
induced contraction of rat pulmonary arteries. Am J Physiol Lung Cell
Mol Physiol 314: L670–L685, 2018. First published December 28,
2017; doi:10.1152/ajplung.00283.2016.—Application of H2S (“sul-
fide”) elicits a complex contraction in rat pulmonary arteries (PAs)
comprising a small transient contraction (phase 1; Ph1) followed by
relaxation and then a second, larger, and more sustained contraction
(phase 2; Ph2). We investigated the mechanisms causing this response
using isometric myography in rat second-order PAs, with Na2S as a
sulfide donor. Both phases of contraction to 1,000 M Na2S were
attenuated by the pan-PKC inhibitor Gö6983 (3 M) and by 50 M
ryanodine; the Ca2 channel blocker nifedipine (1 M) was without
effect. Ph2 was attenuated by the mitochondrial complex III blocker
myxothiazol (1 M), the NADPH oxidase (NOX) blocker VAS2870
(10 M), and the antioxidant TEMPOL (3 mM) but was unaffected by
the complex I blocker rotenone (1 M). The bath sulfide concentra-
tion, measured using an amperometric sensor, decreased rapidly
following Na2S application, and the peak of Ph2 occurred when this
had fallen to ~50 M. Sulfide caused a transient increase in NAD(P)H
autofluorescence, the offset of which coincided with development of
the Ph2 contraction. Sulfide also caused a brief mitochondrial hyper-
polarization (assessed using tetramethylrhodamine ethyl ester), fol-
lowed immediately by depolarization and then a second more pro-
longed hyperpolarization, the onset of which was temporally corre-
lated with the Ph2 contraction. Sulfide application to cultured PA
smooth muscle cells increased reactive oxygen species (ROS) pro-
duction (recorded using L012); this was absent when the mitochon-
drial flavoprotein sulfide-quinone oxoreductase (SQR) was knocked
down using small interfering RNA. We propose that the Ph2 contrac-
tion is largely caused by SQR-mediated sulfide metabolism, which, by
donating electrons to ubiquinone, increases electron production by
complex III and thereby ROS production.
hydrogen sulfide; mitochondria; protein kinase C; pulmonary artery;
rat; reactive oxygen species; sulfide-quinone oxoreductase
INTRODUCTION
Hydrogen sulfide (H2S, hereafter referred to as sulfide)
typically acts as a vasodilator but in some arteries causes
constriction or a complex response that exhibits both constrict-
ing and dilating phases (26). In rat pulmonary arteries (PAs),
for example, application of 1 mM sulfide (as NaHS) to PAs
preconstricted with norepinephrine caused a brief transient
constriction followed by a relaxation and then a second and more
sustained constriction (25). This response resembles the effect of
hypoxia in these arteries, and based on this similarity and other
observations, Olson and coworkers (25, 27) proposed that hypoxic
pulmonary vasoconstriction (HPV) is due to a build-up of cellular
sulfide concentration ([sulfide]) during hypoxia resulting from an
inhibition of its oxidative metabolism.
Although a number of mechanisms, most notably KATP
channel activation (24), have been shown to contribute to the
vasodilating effect of sulfide, the pathways underlying sulfide-
induced vasoconstriction are less well understood. A study in
perfused trout gills (35) showed that the constriction evoked by
100 M sulfide was strongly suppressed by blockers of mito-
chondrial complexes I, III, and IV and by the antioxidant
diethyldithiocarbamate, leading the authors to propose a role
for mitochondrially derived reactive oxygen species (ROS). It
has also been reported (25) that 1 mM NaHS depolarized
bovine PA smooth muscle, which would be predicted to cause
contraction by opening voltage-gated Ca2 channels. In addi-
tion, sulfide can activate several isoforms of protein C in rat
cardiomyocytes (29), an effect that, if it occurred in PA smooth
muscle cells (PASMCs), would be likely to cause contraction.
Evidence has also been presented that low concentrations of
sulfide constricted rat aorta and increased blood pressure by
scavenging nitric oxide (2).
Sulfide has complex effects on mitochondrial respiration
because it can both inhibit and stimulate the electron transport
chain (ETC). The former effect, which accounts for its poison-
ous nature, is due to a block of cytochrome-c oxidase (CCOx),
whereas the latter, which has been described much more
recently, is associated with its metabolism by sulfide quinone
oxoreductase (SQR), a process that feeds electrons into the
ETC by reducing ubiquinone (12, 38). We have presented
evidence in abstract form that the second sulfide-induced
contraction of rat PAs is abolished by the complex III blocker
myxothiazol and is associated with mitochondrial hyperpolar-
ization, leading us to propose that it is caused by an increased
flux of electrons through the distal ETC, which results in an
increased generation of ROS by complex III (1, 8, 31). Here,
we report that sulfide induces ROS production by PASMCs,
which is ablated by SQR knockdown, and that the sustained
sulfide-induced contraction is largely dependent on complex III
and NADPH oxidase.
METHODS
Ethical approval. This study conforms with the Guide for the Care
and Use of Laboratory Animals published by the National Institutes of
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Health (NIH Publication No. 85-23, Revised 1996) and is in accor-
dance with UK Home Office regulations [Animals (Scientific Proce-
dures) Act, 1986; King’s College London Animal Welfare Assurance
number F17-00373]. Male Wistar rats (200–300 g; 6–8 wk old) were
euthanized by lethal injection (intraperitoneal) of sodium thiopental.
Intrapulmonary artery mounting and measurement of tension
development. The heart and lungs were excised and placed in cold
physiological salt solution (PSS) that contained the following (in
mmol/l): 118 NaCl, 24 NaHCO3, 1 MgSO4, 0.435 NaH2PO4, 5.56
glucose, 1.8 CaCl2, and 4 KCl. Rings of the intrapulmonary artery
(IPA; inner diameter: 0.51.0 mm) were dissected free of adventitia
and parenchyma under a dissection microscope, mounted on a con-
ventional small vessel wire myograph, and stretched to give a basal
tension of ~5–6 mN (equivalent to an internal pressure of ~15
mmHg). They were then equilibrated with three brief exposures to
PSS containing 80 mmol/l KCl (80KPSS; isotonic replacement of
NaCl by KCl).
ROS measurements. Rat PASMCs cultured to passage 4 were
transfected using Amaxa electroporation kit with plasmid encoding
either scrambled small interfering (si)RNA or SQR siRNA, seeded in
white 96-well plates and growth arrested for 24 h. Culture medium
was then replaced with warm (37°C) Krebs solution gassed with
air-5% CO2 containing 10 M L-012. Basal luminescence was mea-
sured with a Promega plate reader, solution in wells was replaced with
Krebs containing 1,000 M Na2S, and the plate was incubated at
37°C for 10 min. Cells were then washed twice with Krebs, 10 M
L-012 were added, and luminescence was measured again. As the
L-012 signal without cells was1% of that with cells, no background
subtraction was necessary. Results were expressed as signal increase
over control (i.e., cells not treated with Na2S) in each well, and
average values for control and SQR-silenced cells were compared.
Separate control experiments have shown that incubation without
Na2S caused no significant changes in luminescence.
Estimation of changes in NAD(P)H. Changes in NAD(P)H levels
were assessed as described previously (22). Briefly, the autofluores-
cence of IPA mounted on a myograph was recorded while the
preparation was alternately excited with light at 340 and 380 nm while
fluorescence at 500 nm was recorded. This approach depends on the
fact that NAD(P)H fluorescence at 500 nm is greater when excited
at 340 nm than at 380 nm, such that the 340/380 emission ratio is
proportional to changes in NAD(P)H. Movement of the preparation
does not affect the ratio as it equally affects emission at both
wavelengths.
Estimation of mitochondrial membrane potential. PAs were mounted
in a confocal wire myograph (DMT) set on the stage of inverted
microscope combined with a microspectrofluorimeter (Cairn). Arter-
ies were stretched and stimulated with 80KPSS as described above
and then incubated in PSS containing 1 M tetramethylrhodamine
ethyl ester (TMRE) for ~30 min. The artery was then washed several
times with dye-free PSS, and TMRE emission at 530 nm was
recorded using an excitation wavelength of 490 nm, together with
force. Experiments were started after the TMRE signal had stabilized.
This method was based on the protocol described in the Molecular
Probes handbook (Section 22.3, see https://www.thermofisher.com/
uk/en/home/references/molecular-probes-the-handbook/probes-for-
membrane-potential.html) and depends on the concept that when
TMRE is used in relatively high concentrations, an increase in its
mitochondrial concentration (which occurs during mitochondrial hy-
perpolarization since TMRE is positively charged) will cause a fall in
fluorescence due to self-quenching; likewise fluorescence will in-
crease upon mitochondrial depolarization (3, 18, 21). We validated
this approach in preliminary experiments by showing that FCCP,
cyanide, and antimycin all caused an increase in TMRE fluorescence.
Severe hypoxia also caused an increase in fluorescence that was
reversible upon reimposition of normoxia (not shown).
PCR. RNA was isolated from homogenates of freshly isolated rat
PAs, mesenteric arteries, aorta, brain, and cultured PASMCs. Reverse
transcription of the RNA was carried out as previously described (16).
RT-PCR primer pairs for rat sulfide quinone reductase-like (SQRDL)
were designed using Primer3web version 4.0 (http://primer3.ut.ee)
and synthesized by Sigma-Aldrich (St. Louis, MO). SQRDL (Acces-
sion No. BC158559) primers were sense CTGCAGGACTTCA-
AGGAAGG and antisense CTCTCCCGAATGATCTCCTG. PCR
was carried out using PuReTaq Ready-To-Go PCR Beads (GE
Healthcare, Piscataway, NJ), and the PCR products (reaction equiv-
alent on 20 ng reverse transcribed RNA) were analyzed by electro-
phoresis on 2.8% agarose gels run in TAE buffer (National Diagnos-
tics, Hessle, UK) with PhiX174 DNA/HinfI Marker (Thermoscien-
tific, Waltham, MA).
Cell culture, siRNA design, and cell transfection. PASMCs and
mesenteric artery smooth muscle cells were dispersed from PAs and
mesenteric arteries, respectively, using collagenase (type XI, 2 mg/
ml), trypsin inhibitor (1 mg/ml), and papain (1 mg/ml), and cultured
in DMEM containing 10% FCS as previously described (37).
PASMCs from passages 3–4 were growth arrested in serum-free
medium for 24 h before use; each cell line was verified as smooth
muscle by immunostaining for smooth muscle -actin, calponin, and
desmin (Sigma-Aldrich).
Several siRNAs against SQR were designed as described previously
(16) and tested for knock-down efficiency, and the best were selected for
experimental use. The 19 nucleotide target sequences (SQRDL-
siRNA: position 884–902, GenBank Accession No. BC158559) were
synthesized into 64–65 mer oligonucleotides with BamHI/HindIII
overhangs (Sigma-Aldrich) and cloned into the expression vector
pSilencer 3.0-H1 (Life Technologies, Paisley, UK). The siRNA clone
was purified using an EndoFree Plasmid Maxi Kit (Qiagen, Craw-
ley, UK) and sequenced (Geneservice, Cambridge, UK). PASMCs
were transfected using the Basic Nucleofector Kit for Primary
Mammalian Smooth Muscle Cells and a nucleofector device
(Nucleofector Technology, Lonza, Slough, UK); after 72 h cells
were serum starved for 24 h before use. Transfection efficiency
was 80%, as determined using pmaxGFP (green fluorescent
protein expressing vector) provided in the kit and confirmed by
fluorescence microscopy. Efficiency and selectivity of knockdown
were confirmed by Western blot.
Measurement of [sulfide]. The [sulfide] in PSS was measured and
recorded using a hydrogen sulfide amperometric sensor and an am-
plifier and SensorTrace Suite software from Unisense (Aarhus, Den-
mark).
Application of sulfide. Sulfide was applied to the myograph cham-
ber by adding aliquots of Na2S (500 mM dissolved in PSS) to the
solution. Final Na2S concentrations ranged from 10 to 1,000 M.
Whereas application of 10–100 M Na2S to the solution had no effect
on pH, higher concentrations caused small but transient rise in pH. In
particular 300, 500, and 1,000 M caused an increase in pH, which
peaked at ~10 s (increases of 0.06, 0.1, and 0.2 units, respectively) and
then progressively diminished; at 60 s the pH was elevated by 0.04,
0.06, and 0.1 pH units, and at 3 min 0.02, 0.02, and 0.03 pH units,
respectively. By 5 min, the pH had returned to the level recorded
before Na2S was applied.
RhoA activation. PA segments were incubated for 20 min in
Eppendorf tubes containing PSS or for 10 min in PSS and then 20 min
in PSS containing 500 M Na2S. Tubes were gassed continually with
air/CO2. Tissues were then snap frozen and protein extracted as
previously described (16). Activation of RhoA was assessed using a
RhoA G-LISA Activation Assay (luminescence format) from Cyto-
skeleton (Denver, CO) as described by the manufacturer’s instruc-
tions.
Data analysis and statistics. Data were analyzed using Student’s
paired or unpaired t-test as appropriate. The threshold for statistical
significance for all comparisons was set at P  0.05. GraphPad Prism
was used for all analyses. Summary data values shown in the figures
are the means	 SE. In experiments in which the fall of the [sulfide]
in the myograph chamber was recorded following its injection into the
L671MECHANISMS OF SULFIDE-INDUCED PULMONARY ARTERY CONTRACTION
AJP-Lung Cell Mol Physiol • doi:10.1152/ajplung.00283.2016 • www.ajplung.org
Downloaded from www.physiology.org/journal/ajplung by ${individualUser.givenNames} ${individualUser.surname} (159.092.238.208) on May 4, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.
solution, this process was closely approximated by a monoexponential
function after the concentration had fallen by ~60% from its peak.
This portion of the curve was therefore fitted using the following
equation: [sulfide]t 
 [sulfide]0  ekt  a, where a is constant of
 0, t is time, and k is the rate constant of the exponential decay.
RESULTS
Sulfide induces a biphasic contraction in rat IPAs. Contrac-
tions evoked by Na2S applied on its own were variable, with
many tissues showing no or very small responses, especially at
concentrations 500 M. However, if arteries were first
slightly preconstricted with a low concentration of PGF2,
consistent responses were observed at sulfide concentrations of
10 M (Fig. 1A). At low concentrations (10 and 30 M),
sulfide caused a small monophasic contraction, whereas a
complex response occurred at higher concentrations (100–
1,000 M). This consisted of an initial brief contraction [phase
1 (Ph1)], followed by a relaxation and then a second increase
in tension [phase 2 (Ph2)], which waned with time. The
amplitude of the three components of the response evoked by
1,000 M Na2S, measured at the peaks of the two contractions
and the nadir of relaxation and expressed as the change in
tension from that recorded in 5 M PGF2 just before sulfide
application, is illustrated in Fig. 1B. Note that tension during
the relaxation observed between the two contractions often fell
below the preconstriction level, indicating that this involved an
active vasorelaxation rather than merely the waning of the
initial contraction. Figure 1C illustrates a typical response to
sulfide applied on its own (i.e., in the absence of preconstric-
tion), which was observed in some arteries; under these con-
ditions responses most commonly demonstrated, an initial
shoulder followed by a larger contraction that reached a peak
and then decayed. As depicted in Fig. 1D, left, a typical
response to Na2S in the presence of 5 M PGF2 was observed
when the endothelial nitric oxide synthase inhibitor nitro-L-
arginine methyl ester (L-NAME; 300 M) was applied. Be-
cause L-NAME tended to increase PGF2-induced preconstric-
tion, and this might have artifactually increased the response to
sulfide, we carried out similar experiments using a lower
concentration of PGF2 (0.5 M), which gave a level of
preconstriction similar to that observed in 5 M PGF2 in the
absence of L-NAME, and again saw the usual response to
sulfide (Fig. 1D, right). The responses to both 30 and 1,000
M sulfide were also not significantly affected by endothelial
denudation (Fig. 2).
Contraction induced by sulfide is temporally associated with
changes in NAD(P)H autofluorescence. Since sulfide blocks
CCOx, we explored the role of the mitochondria in the re-
sponse to sulfide by recording the NAD(P)H/NAD(P) ratio, as
an indication of block of the ETC, and simultaneously mea-
sured contraction. As shown in Fig. 3A, application of a range
of concentrations of sulfide caused a rapidly developing and
transient increase in the NAD(P)H/NAD(P) ratio, which be-
came apparent at a concentration of 100 M sulfide and
increased in duration as a function of the sulfide concentration.
As shown more clearly in Fig. 3, B and C, in both the absence
(Fig. 3B) and presence (Fig. 3C) of PGF2 the Ph1 of contrac-
tion began just after the onset of the change in autofluores-
cence, whereas the nadir of the contraction occurred during the
period when the NAD(P)H/NADP ratio was maximal.
The subsequent onset of the Ph2 contraction coincided
closely with the rapid decline of the NAD(P)H/NADP auto-
fluorescence signal to its baseline level. To analyze the tem-
poral overlap of these two events, we calculated the rate of
change (i.e., the slopes) of both signals during the relevant
period by taking the difference between the amplitude of each
signal at each time point and the time point immediately before
it, such that increasing contraction would result in a positive
slope value for the tension signal and falling autofluorescence
would yield a negative slope value for this signal. Figure 3D
depicts the slopes of both signals over a 500-s period encom-
passing the onset of Ph2 of a contraction induced by 300 M
sulfide. It was apparent that the periods during which the
signals were changing overlapped closely.
Moreover, the slopes of both signals exhibited maxima that
occurred at similar times (Fig. 3D). In nine experiments of this
type, the slope of the Ph2 contraction reached its maximum
7 	 11 s before the NAD(P)H/NADP autofluorescence signal
reached its maximum slope, indicating that the reversal of the
sulfide-induced increase in autofluorescence and the Ph2 con-
traction occurred almost simultaneously. The fall in the auto-
fluorescence signal presumably represented unblock of the
CCOx and the ETC; this would be predicted to occur once the
sulfide concentration in the solution, which falls continually
following Na2S application as H2S is lost to the atmosphere
(see Fig. 8 below, and also Ref. 17), reaches a low enough
level.
Contraction induced by sulfide is also temporally associated
with hyperpolarization of the mitochondrial membrane
potential. We also examined the effect of different concentra-
tions of sulfide on the mitochondrial membrane potential ()
using TMRE. As shown in Fig. 4A, low concentrations of
sulfide (10 and 30 M) invariably caused a mitochondrial
hyperpolarization (n 
 11 and 17, respectively). In contrast,
300 M sulfide almost invariably (30/31 arteries) caused a
depolarization. However, in most arteries (21/31), this was
preceded by a brief hyperpolarization, and followed by a more
prolonged hyperpolarization (23/31). The intermediate concen-
tration of 100 M sulfide caused a monophasic hyperpolariza-
tion in some tissues (4/13), while the remainder demonstrated
the type of triphasic response usually observed with 300 M
sulfide. The frequency with which these effects on  were
observed at each sulfide concentration is shown in Fig. 4B.
Figure 5A illustrates an experiment in which the effects of
applying 30 and 500 M sulfide on  and tension were
monitored simultaneously. As in Fig. 1, PGF2 was first
applied to amplify the sulfide-induced contraction; in these
experiments, a somewhat higher concentration of PGF2 (20
rather than 5 M) was used to further magnify the size of the
contraction. This often caused a small depolarization of ,
which we did not study further. The onset of the contraction
induced by 30 M sulfide occurred simultaneously with a
hyperpolarization of . Application of 500 M sulfide then
caused a typical triphasic response of . The initial hyper-
polarization of  coincided with the Ph1 of contraction.
Tension then fell as  depolarized, only to rise again as this
depolarization gave way to a prolonged hyperpolarization.
The close temporal correlation between the onset of the Ph2
contraction and the hyperpolarization of  apparent in Fig.
5A was observed in 10 arteries. We analyzed the rates of
change of both the tension and  signals in these arteries
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Fig. 1. Properties of sulfide-induced contraction in rat pulmonary arteries (PAs). A: representative examples of contractile responses evoked by 10–1,000 M
Na2S in the presence of 5 M PGF2. B: scatterplot showing the amplitudes of the 3 phases of the response to 1,000 M Na2S in PGF2 in 54 individual PAs;
means 	 SE values are shown at the right of each set of points. C: effect of 500 M Na2S in the absence of PGF2. D: representative responses to 1,000 M
Na2S in the presence of 300 M nitro-L-arginine methyl ester (L-NAME) with preconstriction induced by 0.5 (left) or 5 M (right) PGF2.
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using the approach described above for Fig. 3D. Figure 5B
illustrates the slopes of both signals over a 500-s period
beginning ~200 s before the development of the Ph2 contrac-
tion induced in an artery by the application if 500 M sulfide.
Both signals changed over a similar period. On average, the
contraction reached its maximum rate of increase 35 	 11 s
(n 
 10) after the point at which the rate of  hyperpolar-
ization was maximal.
In addition to blocking CCOx, which would be predicted to
depolarize the mitochondria, at lower concentrations sulfide is
also able to stimulate mitochondrial electron flow as a result of
its metabolism by SQR, since during this process SQR is
reduced and passes electrons into the ETC via ubiquinone (38).
We reasoned that the complex effect of sulfide on might be
due to the superimposition of  depolarization caused by
block of CCox on  hyperpolarization due to SQR-mediated
stimulation of the ETC.
In this case, it would be predicted that the hyperpolarization
of  caused by 30 M sulfide, and also the two phases of
hyperpolarization observed in the presence of higher concen-
trations of sulfide, would be preserved in the presence of the
complex 1 blocker rotenone, since electrons from SQR enter
the ETC distal to complex 1 (38).
As shown in Fig. 6A, both the monophasic hyperpolarization
of  evoked by 30 M sulfide and the two hyperpolarizing
phases of the response to 500 M sulfide were still present in
1 M rotenone and were in fact significantly increased in ampli-
tude. Mean results from a number of experiments in which the
effects of 30 and 500 M sulfide on  recorded the presence
and/or absence of rotenone are shown in Fig. 6B.
In contrast to the effect of inhibiting complex 1, it would be
predicted that blocking the ETC distal to ubiquinone should
prevent sulfide-induced hyperpolarization of , since this
would effectively stop the forward flow of electrons through
the ETC. We therefore examined the effect of myxothiazol,
which inhibits the entry into complex 3 of electrons from
ubiquinone.
In line with this prediction, both the monophasic repolariza-
tion induced by 30 M sulfide and the two phases of hyper-
polarization caused by 500 M sulfide were virtually abolished
by myxothiazol (Fig. 7A). A similar blocking effect of myx-
othiazol occurred if it was applied after sulfide-induced hyper-
polarization of  was first recorded in the presence of
rotenone. The mean effects of myxothiazol on sulfide-induced
hyperpolarization of  are shown in Fig. 7B.
Fig. 2. Lack of effect of endothelial denudation on the
contraction to Na2S The trace shows an example of
contractile responses to 30 M and 1,000 M Na2S,
both applied in the presence of 5 M PGF2, in a
pulmonary artery denuded of endothelium (note the
absence of vasorelaxation to 10 M carbachol). The bar
chart (left) presents the means	 SE amplitudes of the 3
phases of the response to 1,000 M Na2S in arteries in
which the endothelium was left intact (black bars; n 

13) or denuded (gray bars; n 
 20). The contractile
responses to 30 M Na2S in endothelium-intact (n
 30)
and -denuded (n 
 9) arteries are shown on the right.
None of the responses were significantly different be-
tween endothelium-intact and -denuded arteries.
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Simultaneous measurements of bath [sulfide] and contraction.
The results described in Figs. 5–7 imply strongly that the Ph2
contraction to high concentrations of sulfide developed as
block of the ETC gave way to its stimulation. We hypothesized
that this was occurring when the sulfide concentration in the
bath, which falls continuously following the addition of
Na2S owing to H2S outgassing (28), reaches a level low
enough for block of CCOx to be relieved. In this case, it
would be expected that the Ph2 contraction would occur
sooner if the sulfide concentration in the solution decayed
more rapidly. We tested this by recording the sulfide con-
centration in the organ bath while monitoring the contrac-
tion. Arteries were preconstricted with PGF2 to magnify
the contraction, 1,000 M Na2S were applied to the solu-
tion, and the rate at which the [sulfide] fell was varied
between experiments by gassing the solution in the myo-
graph chamber more or less vigorously. Figure 8A illustrates
the results of three experiments of this type and demon-
strates that the delay before the second contraction was
shorter when the [sulfide] fell more rapidly. The [sulfide] at
the time of the peak of the Ph2 contraction was similar in
each experiment, even though the time it took for the
concentration to fall to this level varied widely. In 12
experiments of this type, the mean [sulfide] measured at the
peak of the second contraction ranged from 36 to 55 M,
with an average value of 49 	 1.4 M. The fall in the
sulfide signal was closely approximated by a single expo-
nential once the concentration had fallen by ~60% from the
peak (Fig. 8, B and C); this delay probably occurred due to
mixing effects immediately after injection of sulfide and
also because the sensor response is nonlinear at concentra-
tions 300 M sulfide. As shown in Fig. 8D, there was a
good correlation between the time constant of this exponen-
tial phase and the time at which the peak of the second
response was recorded.
It is noteworthy that we were not able to detect a measure-
able rise in [sulfide] following application to the solution of a
high concentration (1,000 M) of the slow-release sulfide
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Fig. 3. Effects of sulfide on NAD(P)H autofluorescence. A: representative experiment showing simultaneous recordings of the effect of 10–1,000 M Na2S on
the NAD(P)H/NADP autofluorescence ratio (gray trace) and tension (black trace) in the absence of PGF2. B and C: representative experiments highlighting the
close temporal relationship between the 2 phases of the contraction and the onset/offset of the increase in the NAD(P)H/NADP autofluorescence ratio evoked
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from the experiment illustrated in B over a 500-s period encompassing the onset of the phase 2 (Ph2) contraction. Traces were smoothed by calculating the
running average of the values over 5 points (i.e., for the tension at time 
 200 s, this was the average of the values recorded at 192, 196, 200, 204, and 208 s),
and then the differences between the resulting smoothed values at each successive point (i.e., that at point 200 s minus that at 196 s) were plotted vs. time. The
autofluorescence was scaled (50) to facilitate visual comparison with the tension (note the scale bars in B).
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donor GYY4137 (n 
 6, not shown). This is probably because
the rate at which sulfide was outgassing from the solution was
faster than its rate of release from GYY4137.
Contractile pathways involved in the response to sulfide. Figure
9 presents the amplitudes of the three phases of the response to
1,000 M Na2S in the presence of 5 M PGF2 under control
conditions (same data as in Fig. 1C, expressed as means	 SE)
and also in the presence of rotenone (1M), myxothiazol (1M),
and the antioxidant TEMPOL (3 mM). Rotenone slightly attenu-
ated the Ph1 contraction, and abolished the subsequent vasorela-
xation, but had no effect on the Ph2 contraction. Myxothiazol,
which also suppressed the vasorelaxation, had no effect on the
initial contraction but strongly inhibited the Ph2 contraction.
TEMPOL also suppressed the Ph2 contraction.
Figure 10 compares the response to 1,000 M Na2S in the
presence of 5 M PGF2 under control conditions to that ob-
served in the presence of the broad spectrum PKC antago-
nist Gö6983 (3 M) and of the NADPH oxidase inhibitor
VAS2870 (10 m). We also examined the effect of 1 M
Y27632 [Rho kinase (ROCK) inhibitor], in this case using arteries
that responded to sulfide in the absence of PGF2 (since Y27632
markedly inhibits the response to PGF2). As shown in Fig. 10C,
the peak response to 500 M sulfide was greatly decreased by
Y27632. As these results indicated the possible involvement of
the RhoA/ROCK pathway in the sulfide-induced response, we
also investigated whether sulfide activated RhoA using a G-LISA
assay, which measures GTP-bound RhoA. The assay was carried
out using arterial segments that were exposed to PSS in the
presence or absence of sulfide for 20 min and then snap frozen and
homogenized. As depicted in Fig. 10B, 500 M sulfide caused a
small but significant increase in RhoA activation.
Figure 11A shows that application of 1 M myxothiazol or
3 M Gö6983 inhibited the response to 30 M sulfide, which
was observed in the presence of 5 M PGF2, although neither
drug significantly affected the contraction evoked by a lower
sulphide concentration (10 M).
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Application of the sulfide precursor cysteine to PGF2-
preconstricted PAs caused a concentration-dependent contrac-
tion (see Ref. 30), which was also greatly attenuated by
myxothiazol or Gö6983 (Fig. 11B).
Figure 12 compares the response to 1,000 M sulfide in the
presence of 5 M PGF2 under control conditions to that seen
in Ca2 free solution (containing 200 M EGTA) and in the
presence of the voltage-gated Ca2 channel antagonist nifedi-
pine (1 M), or the ryanodine receptor (RyR) blockers ryan-
odine (50 M) or dantrolene (30 M). Whereas nifedipine had
no significant effect on the response to sulfide, Ca2 removal
and ryanodine suppressed both phases of contraction. Ryano-
dine also deepened the nadir of the relaxation phase and
dantrolene had the same effect, although it did not significantly
affect either phase of contraction.
Further experiments (not illustrated) demonstrated that
TEMPOL inhibited the contractile response to 30 M sulfide
in the presence of 5 M PGF2 by 59 	 9% (n
 9, P 0.05),
whereas in contrast ryanodine had no effect on this response
(12 	 14% inhibition, n 
 11, ns).
Effect of SQR knockdown on sulfide-induced ROS produc-
tion in cultured PASMCs. To examine the role of SQR in the
response to sulfide, we measured the effect of application of 1,000
M sulfide on ROS production in cultured PASMCs transfected
with siRNA to knock down this enzyme. Figure 13A illustrates
that anti-SQR siRNA, but not scrambled siRNA, markedly dimin-
ished SQR protein expression in PASMCs.
As described in METHODS, the effect of a 10-min treatment of
PASMCs with 1,000 M sulfide on ROS levels, assessed using
the fluorescent probe L012, was assessed in PASMCs treated
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M Na2S). *P  0.05, rotenone vs. control by unpaired t-test.
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with scrambled or anti-SQR siRNA. As depicted in Fig. 13, B
and C, sulfide pretreatment caused a sustained increase in the
L012 signal in the cells treated with scrambled siRNA; this was
absent in cells in which SQR had been knocked down. Figure
13, D and E, illustrates that ROS production by PASMCs was
almost abolished in PASMCs treated with anti-SQR as com-
pared with scrambled siRNA.
DISCUSSION
It has previously been shown that application of 1,000 M
NaHS to preconstricted rat PAs induces a unique triphasic
effect on tension consisting of two phases of contraction
separated by a relaxation (25). This response bears some
resemblance to HPV in these arteries. Based on this similarity
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and other evidence, Olson et al. (27) proposed that HPV is
triggered by an increase in the intracellular concentration of
sulfide, which would be predicted to occur under hypoxic
conditions. We have recently reported that antagonists of the
enzymes that synthesize sulfide do not inhibit HPV, which argues
against this model (30). The present study was carried out as a
complementary approach to examining this hypothesis by deter-
mining to what extent the mechanisms underlying the sulfide
response, which remain obscure, resemble those of HPV.
We used relatively high concentrations of the sulfide donor
Na2S (500 or 1,000 M) in most experiments because these
evoked the HPV-like double contraction, with the second more
sustained component of the sulfide response in these concen-
trations being similar in size to Ph2 of HPV (33) and also
because high cellular levels of sulfide have been proposed to
exist during hypoxia, but we also examined the effects of 30
M Na2S because these are likely to be more physiologi-
cally relevant under normoxic conditions. When using high
sulfide concentrations, we focused mainly on investigating
the Ph2 contraction since its long duration implies it is more
likely to be relevant to the sustained Ph2 of HPV observed
in rat PAs (7).
As described below and illustrated in Fig. 14, we propose
that both the Ph2 contraction at high Na2S concentrations and
the monophasic contraction observed at lower concentrations
are due to sulfide metabolism by SQR, resulting in a stimula-
A
0
10
20
30
40 peak-1 valley peak-2
Time cont
(n=54)
Gö6983
(n=12)
VAS2870
(n=15)
*
*
*
%
 K
 8
0m
M
B
C
control Na2S 500µM
0
50
100
150 *
%
 R
ho
A
 a
ct
iv
at
io
n
Na2S
(500µM)
Y27362 (1µM)
10 min
1 
m
N
Fig. 10. Effects of PKC, Rho kinase (ROCK),
and NADPH oxidase (NOX) inhibitors on the
contractile response to 1,000 M sulfide. A:
amplitudes of the peak of the phase 1 (Ph1)
contraction (white bars), the nadir of the sub-
sequent relaxation (gray bars), and peak of the
phase 2 (Ph2) contraction evoked by 1,000
M Na2S in PAs preconstricted with 5 M
PGF2 under control conditions (left) and in
the presence of Gö6983 (3 M) or VAS2870
(10 M). B: effect of 10 min incubation in
500 M Na2S on RhoA activation, normal-
ized to paired control tissues. C: effect of 1
M Y27632 on the contractile response to
500 M Na2S. *P  0.05, significantly dif-
ferent from the corresponding control value
for that phase.
A B
Co
n1
-10
Co
n1
-30
Co
n2
-10
Co
n2
-30
Co
n-1
0
Co
n-3
0
Gö
-10
Gö
-30
Co
n-1
0
Co
n-3
0
my
xo
-10
my
xo
-30
0
5
10
15
20
25
*
*
control
(n=14)
Gö6983 (3μM)
(n=8)
myxothiazol (1μM)
(n=8)
%
 8
0m
M
 K
1 10 100 1000 10000
0
5
10
15
20
25
30
35
myxothiazol (n=6)
Gö6983 (n=6)
control (n=17)
cysteine [μM]
%
 8
0m
M
 K
Fig. 11. Effects of Gö6983 and myxothiazol on contractions to 10 and 30 M Na2S. A: Amplitude of contractions evoked by two successive applications of 10
or 30 M Na2S in the presence of 5 M PGF2 under control conditions (time controls) and when Gö6983 (3 M) or myxothiazol (1 M) was added to the
bath 30 min before the second application of sulfide. *P  0.05, significant difference between the contractions observed during the 1st and 2nd applications
of sulfide. B: concentration-dependent contraction caused by the sulfide “donor” L-cysteine in PGF2-preconstricted arteries under control conditions and in the
presence of Gö6983 (3 M) or myxothiazol (1 M). *P  0.05, significantly different from the corresponding control value for that phase.
L679MECHANISMS OF SULFIDE-INDUCED PULMONARY ARTERY CONTRACTION
AJP-Lung Cell Mol Physiol • doi:10.1152/ajplung.00283.2016 • www.ajplung.org
Downloaded from www.physiology.org/journal/ajplung by ${individualUser.givenNames} ${individualUser.surname} (159.092.238.208) on May 4, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.
tion of the ETC that leads to an increased production of ROS
by complex III.
The onset of the Ph2 contraction occurs when the sulfide
concentration falls to a level at which unblock of the ETC
occurs and are associated with stimulation of the ETC. It is
important to appreciate that the [sulfide] in solutions open to
the atmosphere decreases rapidly when sulfide is applied as a
Na salt, as it has been in most in vitro studies (17). Our results
show that this fall plays a critical role in shaping the biphasic
nature of the response to 100 M sulfide, such that the Ph2
contraction develops only when the [sulfide] in the solution has
fallen to a low level.
The rate at which the [sulfide] in the solution fell varied
between experiments, an effect that could to some extent be
controlled by gassing the solution in the myograph chamber
more or less vigorously. Using this approach, we found that the
rate at which the solution [sulfide] fell was correlated with the
delay before the Ph2 contraction developed (Fig. 8), such that
the peak of the Ph2 contraction invariably occurred at a time
when the [sulfide] had fallen into a narrow concentration range
near 50 M, regardless of how long it took for this to occur.
In separate experiments, simultaneous measurement of ten-
sion and NAD(P)H autofluorescence, the latter used as an
indicator of ETC inhibition, demonstrated that the onset of the
Ph2 contraction coincided with the fall in the autofluoresce-
nce signal evoked by 100 M sulfide (Fig. 3), the abrupt
nature of which was consistent with the requirement for three
sulfide molecules to bind in order for cytochrome-a3 blockade
to occur (38).
Taken together, the results shown in Figs. 3, 5 and 8 indicate
that the Ph2 contraction occurred when the cytosolic [sulfide]
fell sufficiently for complex IV to become unblocked. Al-
though it could alternatively be argued that Ph2 was a delayed
result of the previous ETC blockade, perhaps triggered by
depolarization of  and a consequent shift of Ca2 from the
mitochondria to the cytoplasm, the virtual simultaneity of the
onset of Ph2 and the fall in NAD(P)H autofluoresence sug-
gested that this was not the case. Moreover, the observation
that applying low concentrations of Na2S (10 and 30 M)
caused a sustained monophasic contraction without any block
of the ETC (as evidenced by the absence of any increase in
NAD(P)H autofluorescence) implied strongly that sulfide-in-
duced contraction was not dependent on block of the ETC or
mitochondrial depolarization.
Instead the results indicated that sulfide-induced contraction
was invariably associated with mitochondrial hyperpolarization.
Higher concentrations of sulphide (300–1,000 M) caused a
triphasic change in , consisting of a very brief initial hyper-
polarization, followed by a depolarization and then a second,
prolonged hyperpolarization. This response was more promi-
nent if the mitochondria were first depolarized by rotenone.
Simultaneous recording of  and tension in both the absence
and presence of rotenone demonstrated that onset of the Ph2
contraction was closely associated with the second hyperpo-
larization of . Lower concentrations of sulfide (10 and 30
M), which caused only a hyperpolarization of , evoked a
monophasic contraction.
These results demonstrate that both the Ph2 contraction
evoked after a delay following application of high [sulfide] and
the immediate monophasic contraction caused by lower con-
centrations were associated with stimulation of the ETC. Al-
though sulfide has long been known to block the ETC (9), with
a reported IC50 in intact cells of several micromolar (e.g., Ref.
4), it has more recently become clear that at lower concentra-
tions it stimulates the ETC. Elegant studies by Bouillard and
colleagues (12, 19, 38) have established that this effect, which
may predominate at low micromolar [sulfide], is due to its
metabolism by a sulfide oxidation unit consisting of SQR, a
dioxygenase and a sulfur transferase. SQR is reduced during
this process and passes two electrons into the ETC, thereby
increasing mitochondrial respiration. Stimulation of the ETC
probably dominates in an even higher sulfide concentration
range in intact arteries, as it has been shown (17) that [sulfide]
up 100 M increased mitochondrial O2 consumption in intact
aorta.
Given that sulfide-induced contraction was associated with
an index of ETC stimulation (hyperpolarization of ), we
reasoned that the Ph2 might depend, at least in part, on sulfide
metabolism by SQR and the resulting increase in mitochondrial
electron flow. It would be predicted that this process would be
inhibited while the [sulfide] is high enough to block the ETC,
but would then develop when the [sulfide] falls enough for
unblock of complex IV to occur, thereby explaining why the
Ph2 contraction is delayed until the offset of the NAD(P)H
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Fig. 12. Effects of Ca2 free solution, nifedipine, ryanodine,
and dantrolene on the contractile response to 1,000 M Na2S.
Bars indicate the amplitudes of the peak of the phase 1 (Ph1)
contraction (white bars), the nadir of the subsequent relaxation
(gray bars), and peak of the phase 2 (Ph2) contraction (black
bars) evoked by 1,000 M Na2S in PAs preconstricted with 5
M PGF2 under control conditions (left), in Ca2 free solu-
tion containing 200 M EGTA, and in the presence of 30 M
dantrolene, 1 M nifedipine, or 50 M ryanodine. Numbers of
replicates under each condition are shown. *P  0.05, signif-
icantly different from the corresponding control value for that
phase.
L680 MECHANISMS OF SULFIDE-INDUCED PULMONARY ARTERY CONTRACTION
AJP-Lung Cell Mol Physiol • doi:10.1152/ajplung.00283.2016 • www.ajplung.org
Downloaded from www.physiology.org/journal/ajplung by ${individualUser.givenNames} ${individualUser.surname} (159.092.238.208) on May 4, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.
autofluorescence signal and the second hyperpolarization of
, both of these events being indicative of a resumption of
electron flow. This mechanism is also consistent with the
immediate hyperpolarization of  and the monophasic con-
traction observed upon the application of 10 and 30 M
sulfide. Similarly, the entry of electrons from SQR into the
ETC at coenzyme Q (between complex I and III) would
explain why the Ph2 contraction was attenuated by myxothia-
zol, which blocks electron entry into complex III, but not
rotenone, which blocks complex I.
Generation of ROS by complex III has been identified as
being responsible for initiating HPV (39, 41), and we propose
that the interaction of H2S with SQR also increases ROS
production by complex III. In particular, sulfide-induced hy-
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Fig. 13. Evidence for a role of sulfide-quinone oxoreductase (SQR) in sulfide-induced reactive oxygen species (ROS) production. A: expression of SQR mRNA
in homogenates from segments of rat pulmonary artery, mesenteric artery, cultured pulmonary artery smooth muscle cells (PASMCs), aorta, and whole brain.
B: example of immunoblot showing SQR protein bands in homogenates from PASMCs treated with either scrambled or anti-SQR small interfering RNA. C: mean
effect of anti-SQR siRNA observed in 7 experiments of the type shown in B. D: an example of an experiment in which L-012 luminescence was recorded in
cells treated with scrambled (top set of points) or anti-SQR siRNA (bottom set of points) is shown on the left. Recordings were made immediately after cells
were incubated in PSS containing 1,000 M Na2S for 10 min and washed twice with PSS. The dashed lines indicate the level of luminescence in cells not treated
with sulfide (i.e., the control level), recorded in triplicate. E: values at each time point, expressed as %control, were averaged, and the mean results from 5
experiments carried out using the same protocol. *P  0.05, scrambled siRNA vs. SQR si RNA.
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perpolarization of  would be predicted to increase ROS
release by the mitochondria by increasing the lifetime of
semireduced species such as ubisemiquinone, which can do-
nate electrons to O2 to form superoxide, and also by increasing
the driving force for superoxide to move into the mitochondrial
intermembrane space where it can be converted to H2O2, which
then enters the cytoplasm (13, 42). The block of the ETC
during the period where the sulfide concentration is high could
further promote the subsequent Ph2 contraction by preventing
SQR oxidation and thereby rendering it highly reduced, thus
setting the stage for it to fuel a complex III-mediated “burst” of
ROS production when the [sulfide] falls enough to unblock
cytochrome-a3.
This model is supported by the strong expression of SQR in
rat PAs and PASMCs and the abolition by anti-SQR siRNA of
the ROS production that occurred when PASMCs were treated
with sulfide and then washed to allow the unblocking of
complex IV. Moreover, the antioxidant TEMPOL strongly
suppressed the Ph2 contraction (Fig. 9). As we have previously
shown that ROS produce a Rho kinase-dependent constriction
of these arteries (15), additional observations that were con-
sistent with a role for ROS in the response to sulfide were its
sensitivity to Y27632 and also the sulfide-induced activation of
RhoA (Fig. 10). Additionally, Skovgaard and Olson (35) have
demonstrated that the contraction of trout gills to sulfide was
inhibited by mitochondrial blockers and the antioxidant dieth-
yldithiocarbamate.
Role of PKC and NADPH oxidase. Sulfide has been shown
to cause a rapid activation of PKCε in cardiomyocytes (5), an
effect that is thought to be involved in ischemic precondition-
ing (29). We observed that the nonselective PKC blocker
Gö6983 attenuated both phases of the sulfide-induced contrac-
tion. Interestingly, the NOX inhibitor VAS2870 had a similar
effect on the Ph2 contraction. PKC activation induces contrac-
tion in PAs and other arteries (40), and several PKC isoforms,
including PKCε, stimulate NOX (20). We have recently shown
that the sphingolipid sphingosylphosphorylcholine strongly
potentiates PA contraction via a ROS-dependent pathway in-
volving the activation of NOX1 by PKCε (34). Additionally,
mitochondrial ROS produced from complex III have been
shown to activate NOX by stimulating PKCε in PASMCs (32).
Role of Ca2-elevating pathways in the sulfide response.
Although we focused mainly on the involvement of the mito-
chondria in the sulfide response, we also examined the poten-
tial involvement of several potential downstream Ca2-elevat-
ing mechanisms. Nifedipine had no effect on either phase of
the response to 1,000 M sulfide, indicating the lack of
involvement of voltage-gated Ca2 channels. Conversely, ry-
anodine, at a concentration that blocks all three RyR isoforms,
markedly suppressed the Ph1 and Ph2 contractions and also
deepened the nadir of the intervening relaxation, suggesting
that the major source of Ca2 throughout the sulfide response
was SR Ca2 release via the RyR. Although dantrolene, which
blocks RyR1 and 3 (14), also enhanced the relaxation, it had
little effect on either phase of contraction, indicating that RyR2
probably plays the predominant role in sulfide-induced Ca2
release. Interestingly, it has been demonstrated (23) that ROS
induce Ca2 release by the RyR2 receptor in PASMCs by
causing its dissociation from FKBP12.6, and there is evidence
that SR expressing RyR2 is dispersed widely within PASMCs,
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NAD(P)H
autofluor.
tension
Ph1
nadir
Ph2
Ph2
High [Na2S] Low [Na2S]
Ph1
Nadir
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Fig. 14. Proposed mechanisms of sulfide-induced contraction. Shown on the left and middle are the effects of applying (at the arrows) high (300–1,000 M) and
low (30 M) Na2S concentrations to the myograph solution chamber on the solution sulfide concentration (trace A), NAD(P)H autofluorescence (trace B),
mitochondrial membrane potential (trace C), and tension development (trace D) observed in rat pulmonary arteries. The 2 phases of contraction, separated by
the intervening relaxation to a tension nadir, are indicated. One the right, the events observed or proposed to occur during each of these 3 phases of the response
to high concentrations of sulfide are shown, as are their proposed relationships to each other. The events following the application of a low concentration of sulfide
are proposed to be similar to those occurring during Ph2 of the response to high sulfide concentrations: metabolism of sulfide by SQR leading to electron transport
chain (ETC) stimulation, hyperpolarization of , ROS production by complex 3, and contraction. No nadir of contraction occurs with 30 M Na2S because
the cellular sulfide concentration never gets high enough to block the ETC and therefore ROS production. In both high and low concentrations of sulfide,
stimulation of PKC, likely caused by sulfide-induced thiol signaling, also enhances tension development throughout the response. CCOx, cytochrome-c oxidase.
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unlike RyR1 and 3, which demonstrate a subplasmalemmal
and perinuclear distribution, respectively (6, 11).
As described above, both the Ph2 contraction and the mono-
phasic response to 30 M sulfide were associated with mito-
chondrial hyperpolarization. Furthermore, both responses were
similarly inhibited by myxothiazol, Gö6983, and TEMPOL,
implying that both responses share a common mechanisms:
stimulation of the ETC, mitochondrial ROS production, and
stimulation protein kinase C. However, ryanodine, which at-
tenuated the Ph2 contraction to 1,000 M sulfide, did not affect
the response to 30 M sulfide. A possible explanation for this
is that whereas ROS production by 1,000 M sulfide is
sufficient to cause SR Ca2 release, this is not the case with the
lower concentration.
Mechanisms of the Ph1 contraction. The Ph1 contraction to
1,000 M Na2S occurred during a period in which the effects
of sulfide on the mitochondria were in very rapid flux, making
it difficult to determine the extent to which these events were
playing a role in evoking this contraction. However, this
contraction was slightly but significantly attenuated by rote-
none. We therefore speculate that Ph1 could have been due in
part to increased ROS production by complex I owing to a
reverse flow of electrons entering the ETC as the very high
concentration of sulfide was metabolized by SQR, although
more work will be necessary to determine the validity of this
idea. On the other hand, the lack of effect of myxothiazol on
Ph1 indicates that ROS production by complex III was not
involved. Although it is therefore unclear whether the mito-
chondria were involved in Ph1, its unambiguous block by
Gö6983 and ryanodine indicates that this contraction was
dependent on both PKC and RyR-mediated Ca2 release from
the SR. In any case, the fact that Ph1 contraction was occurring
during a period when the cellular sulfide concentration in cells
was almost certainly very high means that its physiological
relevance is questionable. It is also possible that the transient
increase in pH during the first several minutes after the appli-
cation of 300–1,000 M Na2S might have affected the ampli-
tude of Ph1, most likely by attenuating it as alkalinization has
been shown to relax PAs (10).
Block of L-cysteine-induced contraction by myxothiazol and
Gö6983. L-cysteine, the main cellular source of sulfide, causes
an increase in tension in PGF2-preconstricted PAs that is
prevented by PAG, a blocker of the sulfide-synthesizing en-
zyme cystathionine--lyase. Unlike Na2S, L-cysteine elicits a
monophasic and sustained increase in tension, as well as a
linear release of sulfide from liver, both effects implying that
its application causes a steady increase in the cellular [sulfide]
(30). As shown in Fig. 11B, both myxothiazol and Gö6983
strongly suppressed the increase in tension evoked by L-cys-
teine over a wide range of concentrations. This suggests that
the mechanisms we have described for the contraction caused
by Na2S may also occur with smaller and more sustained
increases in the cellular [sulfide] that are likely to be more
physiologically relevant.
Sulfide and HPV: similarities and differences. A comparison
of the mechanisms of the Ph2 contractile response to sulfide in
rat PAs described in this study and those we have previously
reported for HPV in the same arteries (7) reveals a number of
similarities but two important differences. The sustained con-
tractile responses to sulfide and hypoxia are both sensitive to
blockade by ryanodine, Y-27632, Gö6983, TEMPOL, and
myxothiazol and both insensitive to nifedipine. On the other
hand, the Ph2 sulfide-induced contraction is inhibited by the
NADPH oxidase blocker VAS 2870, which has no effect on
HPV (7). Moreover, HPV is abolished by 1 M rotenone (22,
41), which however had no significant effect on the sustained
phase of the sulfide response.
The mechanisms by which hypoxia constricts PAs remain
controversial, but there is substantial evidence that HPV is
triggered by increased ROS production by complex III (22,
41), leading to SR Ca2 release and the opening of store
operated Ca2 channels, as well as activation of Rho kinase. In
this case, a substantial degree of similarity between the re-
sponses to sulfide and hypoxia would be predicted if sulfide
also increases ROS production via complex III. However, the
observation that rotenone and VAS 2870 exert differential
effects on HPV and the sulfide response argues against the
concept that sulfide may mediate HPV via this pathway, and,
more generally, does not support a crucial role for sulfide in
HPV.
Conclusion. In summary, our observations offer a coherent
explanation for the unique biphasic contraction induced in PAs
by high concentrations of sulfide, while at the same time
suggesting that a smaller but more sustained increase in cellu-
lar [sulfide] may activate similar pathways. Given the appar-
ently widespread expression of SQR in the vasculature, and
since ROS tend to exert complex effects on contraction in
systemic as well as PAs (e.g., Ref. 36), the mechanisms we
describe may have a wider implications for the vascular system
as a whole.
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